Black Diamond Therapeutics, Inc. (BDTX): Weighted Average Diluted Shares
57.56M
Year ended 2025-12-31
+16.6%
3-year compound annual growth
+11.8%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 57.56M | +4.6% | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | 55.03M | +25.2% | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | 43.95M | +21.0% | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | 36.33M | +0.4% | 2024-03-12, From 2022-01-01 |
| 2021-12-31 | 36.19M | +10.0% | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | 32.91M | n/a | 2022-03-17, From 2020-01-01 |